Conjunctival grafting for ocular surface disease

Current Opinion in Ophthalmology

Volumn 10, Issue 4, 1999, Pages 277-281

  Tan, Donald ^a  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ADJUVANT THERAPY; AMNION; AUTOGRAFT; CLINICAL TRIAL; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA LIMBUS; ELECTRON THERAPY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PTERYGIUM; RANDOMIZED CONTROLLED TRIAL; REVIEW;

AMNION; CONJUNCTIVA; EPITHELIAL CELLS; HUMANS; LIMBUS CORNEAE; PTERYGIUM; TRANSPLANTATION, AUTOLOGOUS;

EID: 0033499094     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199908000-00010     Document Type: Review

References (39)

1. 1 Thoft RA: Conjunctival transplantation. Arch Ophthalmol 1977, 95:1425-1427.
2. 2 Kenyon KR, Wagoner MD, Hettinger ME: Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 1985, 92:1461-1470.
3. 3 Lewallen S: A randomized trial of conjunctival autografting for pterygium in the topics. Ophthalmology 1989, 96:1612-1614.
4. 4 Chen PP, Ariyasu RG, Kaza V, LaBree LD, McDonnell PJ: A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol 1995, 120:151-160.
5. 5 Tan DTH, Chee SP, Dear KBG, Lim ASM: Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 1997, 115:1235-1240.
6. 6 Manning CA, Kloess PM, Diaz MD, Yee RW: Intraoperative mitomycin in primary pterygium excision. Ophthalmology 1997, 104:844-848.
7. 7 Prabhasawat P, Barton K, Burkett G, Tseng SCG: Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 1997, 104:974-985.
8. 8 Snibson GR, Luu CD, Taylor HR: Pterygium surgery in Victoria: a survey of ophthalmologists. Aust N Z J Ophthalmol 1998, 26:271-276.
9. 9 Sebban A, Hirst LW: Treatment of pterygia in Queensland. Aust N Z J Ophthalmol 1991, 19:123-127.
10. 10 Sánchez-Thorin JC, Rocha G, Yelin JB: Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium. Br J Ophthalmol 1998, 82:661-665. This meta-analysis on recurrence rates after various surgical procedures for primary pterygium proves conclusively that bare sclera resection is inferior to other forms of pterygium surgery and should no longer be done routinely. However, the study shows no significant differences in recurrence rates with conjunctival autografting and bare sclera excision combined with mitomycin C. Limitations of this study include the paucity of randomized, controlled, clinical trials and the fact that appropriate studies on β-irradiation were not available for comparison.
11. 11 Jap A, Chan C, Lim L, Tan DTH: Conjunctival rotation autograft for pterygium. Ophthalmology 1999, 106:67-71. This study evaluated a modification of conventional conjunctival autografting in which the original epithelium from the pterygium is re-applied after a 180° rotation. Conjunctival rotation autografting does not require the harvesting of superior bulbar conjunctiva, and it is therefore a useful alternative in cases in which conventional autografting is contraindicated or difficult.
12. 12 Kim S, Yang Y, Kim J: Primary pterygium surgery using the inferior conjunctival transposition flap. Ophthalmic Surg and Lasers 1998, 29:608-611.
13. 13 Shimazaki J, Shinozaki N, Tsubota K: Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol 1998, 82:235-240. Limbal autograft transplantation combined with AMT is an advanced surgical procedure for selected patients with severe pterygium recurrence, scarring, and symblepharon. The rationale for using amniotic membrane is that it reduces postoperative scarring and recurrence of symblepharon.
14. 14 Shimazaki J, Yang H-Y, Tsubota K: Limbal autograft transplantation for recurrent and advanced pterygia. Ophthalmic Surg and Lasers 1996, 27:917-923.
15. 15 Forbes J, Collin R, Dart J: Split thickness buccal mucous membrane grafts and β irradiation in the treatment of recurrent pterygium. Br J Ophthalmol 1998, 82:1420-1423.
16. 16 Clinch TE, Goins KM, Cobo LM: Treatment of contact lens-related ocular surface disorders with autologous conjunctival transplantation. Ophthalmology 1992, 99:634-638.
17. 17 Vastine DW, Stewart WB, Schwab IR: Reconstruction of the periocular mucous membrane by autologous conjunctival transplantation. Ophthalmology 1982, 89:1072-1081.
18. 18 Herman WK, Doughman DJ, Lindstrom RL: Conjunctival autograft transplantation for unilateral ocular surface diseases. Ophthalmology 1983, 90:1121-1126.
19. 19 Kwitko S, Marinho D, Barcaro S, Bocaccio F, Rymer S, Fernandes S, Neumann J: Allograft conjunctival transplantation for bilateral ocular surface disorders. Ophthalmology 1995, 102:1019-1025.
20. 20 Tseng SCG : Concept and application of limbal stem cells. Eye 1989, 3:141-157.
21. 21 Tsai RJ-F, Sun T-T, Tseng SCG: Comparison of limbal and conjunctival autograft transplantation in corneal surface reconstruction in rabbits. Ophthalmology 1990, 97:446-455.
22. 22 Kenyon KR, Tseng SCG: Limbal autograft transplantation for ocular surface disorders. Ophthalmology 1989, 96:709-723.
23. 23 Tsai RJ-F, Tseng SCG: Human allograft limbal transplantation for corneal surface reconstruction. Cornea 1994, 13:389-400.
24. 24 Tsubota K, Toda I, Saito H, Shinozaki N, Shimazaki J: Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology 1995, 102:1486-1496.
25. 25 Tan DTH, Ficker LA, Buckley RJ: Limbal transplantation. Ophthalmology 1996, 103:29-36.
26. 26 Kato T, Yamaguchi T, Hamanaka T, Kanai A: Corneal marginal ulcer in relapsing polychondritis:treatment with keratoepithelioplasty. Ophthalmic Surg and Lasers 1998, 29:767-769.
27. 27 Dua HS: The conjunctiva in corneal epithelial wound healing. Br J Ophthalmol 1998, 82:1407-1411. Dua shows that in the presence of partial limbal stem cell deficiency, the careful, repeated removal of conjunctival overgrowth onto the cornea preferentially allows corneal re-epithelization. Dua suggests that this replacement of conjunctival epithelium with corneal epithelial cells may be important in explaining the phenomenon of conjunctival differentiation and is a therapeutic option in eyes with partial limbal stem cell deficiency.
28. 28 Pery JF, Siganos CS, Solomon A, Scheman L, Brautbar C, Zauberman H: Limbal cell autograft transplantation for severe ocular surface disorders. Graefes Arch Clin Exp Ophthalmol 1998, 236:582-587.
29. 29 Manche EE, Afshari MA, Singh K: Delayed corneal epitheliopathy after antimetabolite-augmented trabeculectomy. J Glaucoma 1998, 7:237-239.
30. 30 Haamann P, Jensen OM, Schmidt P: Limbal autograft transplantation. Acta Ophthalmol Scand 1998, 76:117-118.
31. 31 Croasdale CR, Schwartz GS, Malling JV, Holland EJ: Keratolimbal allograft: recommendations for tissue procurement and preparation by eye banks, and standard surgical technique. Cornea 1999, 18:52-58. This paper lays down important concepts and recommendations to eye banks about procurement of limbal tissue for limbal transplantation. The use of pediatric tissue, an adequate supply of tissue obtained by using both eyes from a single donor, and careful attention to the graft epithelial surface are important factors in ensuring optimal transplantation of limbal stem cells.
32. 32 Kim JC, Tseng SCG: Transplantation of preserved human amniotic membrane tor surface reconstruction in severely damaged rabbit corneas. Cornea 1995, 14:473-484.
33. 33 Tsubota K, Satake Y, Ohyama M: Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 1996, 122:38-52.
34. 34 Shimazaki J, Yang H-Y, Tsubota K: Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology 1997, 104:2068-2076.
35. 35 Lee S, Tseng S: Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 1997, 123:303-312.
36. 36 Tseng S, Prabhasawat P, Lee S: Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol 1997, 124:765-774.
37. 37 Tseng SCG, Prabhasawat P, Barton K, Gray T, Meller D: Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 1998, 116:431-441. Previous studies confirmed the usefulness of amniotic membrane in ocular surface transplantation, and Tseng et al. now show that AMT alone may be sufficient to treat eyes with partial limbal deficiency with superficial involvement. It is postulated that reduction of ocular surface inflammation and vascularization by the presence of amniotic membrane is responsible for stabilization of the ocular surface in these eyes.
38. 38 Fukuda K, Chikama T, Nakamura M, Nishida T: Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea 1999, 18: 73-79. The distribution of α-subchains of type IV collagen in amniotic membrane is identical to that in normal conjunctiva but different from that in cornea. This suggests that amniotic membrane may be an ideal replacement for conjunctiva because the two tissues share basement membrane properties.
39. 39 Alino AM, Perry HD, Kanellopoulos AJ, Donnenfeld ED, Rahn ED: Conjunctival flaps. Ophthalmology 1999, 105:1120-1123.